About Visgenx
Visgenx is a private company based in San Diego, California, incorporated in 2018 in Delaware. It has reported $9,166,198 raised in three offerings on Form D since July 2019. Its chief executive is William Pedranti.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 2, 2023 | Jun 14, 2023 | $2,763,915of $3.4M target | 17 | $162K | EquityRule 506(b) | Form D ↗ |
| May 11, 2020 | May 20, 2020amended Aug 17, 2020 | $5,747,283fully sold | 30 | $191K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 12, 2019 | Jul 30, 2019 | $655,000of $2.2M target | 4 | $163K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, three offerings | $9,166,198 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Visgenx's Form D filed Jun 14, 2023.
Earlier filings also listed Santosh Vetticaden, M.D., Ph.D., MBA (executive officer and director, last listed Aug 2020), Frank Douglas, M.D., Ph.D. (director, last listed Aug 2020), Santosh Vetticaden (president & ceo, director, last listed Jul 2019), Martin Emanuele (executive officer and director, last listed Jul 2019) and Frank Douglas (director, last listed Jul 2019).